Intrinsiqq
BioVie Inc. logo

BioVie Inc. Insider Trading

BIVI

Compare
Cluster buy

4 insiders bought 49K of their own stock in 2 days.

Open-market purchases by executives and directors between Aug 27 and Aug 28. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market
+55K
6 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Nov 2026
Nov 18, 2026

Get an email when BIVI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 18
    Cuong V Do
    President & CEO · bought 2,500 at $1.00
    2K
    13% of stake
  • Nov 13
    Cuong V Do
    President & CEO · bought 2,500 at $1.16
    3K
    16% of stake
  • Aug 28
    Joseph M Palumbo
    Chief Medical Officer · bought 4,843 at $2.16
    10K
    406% of stake
  • Aug 28
    Amy Suzon Chappell
    Director · bought 727 at $2.16
    2K
    New position
  • Aug 28
    Joanne Wendy Kim
    Chief Financial Officer · bought 2,500 at $2.18
    5K
    266% of stake
  • Aug 27
    Cuong V Do
    President & CEO · bought 15,210 at $2.08
    32K
    1677% of stake
  • Aug 7, 2025
    Cuong V Do
    President & CEO · bought 5,000
    —
    100% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BIVI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BIVI

CompareIntrinsic value
ROIVRoivant Sciences Ltd
$38.66-0.78%42
FHTXFoghorn Therapeutics Inc.
$1.72-3.37%46
OCULOcular Therapeutix Inc.
$5.57-4.95%10
TNGXTango Therapeutics Inc.
$21.73-4.32%25
PVLAPavella Therapeutics Inc.
$143.21-1.76%40
XERSXeris Biopharma Holdings, Inc.
$16.97+2.11%34
ACADAcadia Pharmaceuticals Inc.
$17.38-1.19%71
PTGXProtagonist Therapeutics Inc.
$121.40-2.11%62

Spot a number that looks wrong? Check it in BIVI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing BIVI

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.